Assignee
CHIMERA BIOENGINEERING INC
US·22 granted patents·12 pending applications·92 citations·filing 2016–2025
Top patents by PatentIndex Score
34 records- 0197US10669549B2Gold optimized CAR T-cellsCHIMERA BIOENGINEERING INC·Filed 2020·Granted Jun 2, 2020·7 cites·20 claims
- 0296US11535853B2Gold optimized CAR T-cellsCHIMERA BIOENGINEERING INC·Filed 2022·Granted Dec 27, 2022·2 cites·20 claims
- 0396US9777064B2Smart CAR devices, DE CAR polypeptides, side CARs and uses thereofCHIMERA BIOENGINEERING INC·Filed 2016·Granted Oct 3, 2017·19 cites·13 claims
- 0495US11648277B2Combination therapy with gold controlled transgenesCHIMERA BIOENGINEERING INC·Filed 2022·Granted May 16, 2023·2 cites·20 claims
- 0595US11311577B2Coordinating gene expression using RNA destabilizing elementsCHIMERA BIOENGINEERING INC·Filed 2021·Granted Apr 26, 2022·4 cites·12 claims
- 0694US11572566B2Gold optimized CAR t-cellsCHIMERA BIOENGINEERING INC·Filed 2022·Granted Feb 7, 2023·2 cites·20 claims
- 0794US10688132B2Coordinating gene expression using RNA destabilizing elementsCHIMERA BIOENGINEERING INC·Filed 2019·Granted Jun 23, 2020·8 cites·17 claims
- 0894US10675305B2Coordinating gene expression using RNA destabilizing elementsCHIMERA BIOENGINEERING INC·Filed 2019·Granted Jun 9, 2020·8 cites·19 claims
- 0994US10323248B2Gold optimized CAR T-cellsCHIMERA BIOENGINEERING INC·Filed 2017·Granted Jun 18, 2019·11 cites·13 claims
- 1093US10472637B2Gold optimized CAR T-cellsCHIMERA BIOENGINEERING INC·Filed 2019·Granted Nov 12, 2019·8 cites·20 claims
- 1193US10323249B2Gold optimized CAR T-cellsCHIMERA BIOENGINEERING INC·Filed 2018·Granted Jun 18, 2019·9 cites·14 claims
- 1291US11110125B2Coordinating gene expression using RNA destabilizing elementsCHIMERA BIOENGINEERING INC·Filed 2019·Granted Sep 7, 2021·4 cites·13 claims
- 1390US11459572B2Gold optimized CAR T-cellsCHIMERA BIOENGINEERING INC·Filed 2019·Granted Oct 4, 2022·2 cites·20 claims
- 1486US10858660B2Gold optimized CAR T-cellsCHIMERA BIOENGINEERING INC·Filed 2020·Granted Dec 8, 2020·1 cites·20 claims
- 1584US10508152B2Smart CAR devices, DE CAR polypeptides, side CARs and uses thereofCHIMERA BIOENGINEERING INC·Filed 2017·Granted Dec 17, 2019·2 cites·20 claims
- 1683US2022325288A1Gold Optimized CAR Natural Killer cellsCHIMERA BIOENGINEERING INC·Filed 2022·Application pending·0 cites
- 1782US10222369B2Methods for making novel antigen binding domainsCHIMERA BIOENGINEERING INC·Filed 2017·Granted Mar 5, 2019·1 cites·20 claims
- 1882US2022228156A1Gold Optimized CAR T-cellsCHIMERA BIOENGINEERING INC·Filed 2022·Application pending·0 cites
- 1980US11497774B2Coordinating gene expression using RNA destabilizing elementsCHIMERA BIOENGINEERING INC·Filed 2022·Granted Nov 15, 2022·0 cites·20 claims
- 2080US11085917B2Methods for making novel antigen binding domainsCHIMERA BIOENGINEERING INC·Filed 2019·Granted Aug 10, 2021·1 cites·10 claims
- 2179US2021292771A1Gold Optimized CAR T-cellsCHIMERA BIOENGINEERING INC·Filed 2021·Application pending·0 cites
- 2277US11052111B2Smart CAR devices and DE CAR polypeptides for treating disease and methods for enhancing immune responsesCHIMERA BIOENGINEERING INC·Filed 2016·Granted Jul 6, 2021·1 cites·5 claims
- 2376US11718929B2Methods for making novel antigen binding domainsCHIMERA BIOENGINEERING INC·Filed 2021·Granted Aug 8, 2023·0 cites·10 claims
- 2476US2020385741A1Gold Optimized CAR T-cellsCHIMERA BIOENGINEERING INC·Filed 2020·Application pending·0 cites
- 2575US2021290679A1Coordinating Gene Expression Using RNA Destabilizing ElementsCHIMERA BIOENGINEERING INC·Filed 2021·Application pending·0 cites
- 2671US2025206805A1Combination Therapy with Gold Controlled TransgenesCHIMERA BIOENGINEERING INC·Filed 2025·Application pending·0 cites
- 2769US11530272B2Smart car devices, DE car polypeptides, side CARs and uses thereofCHIMERA BIOENGINEERING INC·Filed 2017·Granted Dec 20, 2022·0 cites·5 claims
- 2866US2021332381A1Ligand Matched Transcription Control, Control Devices, and Solute CarriersCHIMERA BIOENGINEERING INC·Filed 2021·Application pending·0 cites
- 2965US2021046117A1Combination Therapy with Gold Controlled TransgenesCHIMERA BIOENGINEERING INC·Filed 2020·Application pending·0 cites
- 3063US2024425560A1IL-18 Variants and Uses ThereofCHIMERA BIOENGINEERING INC·Filed 2022·Application pending·0 cites
- 3162US2025281638A1Compositions and Methods for Activating Natural Killer CellsCHIMERA BIOENGINEERING INC·Filed 2022·Application pending·0 cites
- 3260US2023028899A1Mercury Controlled Gene ExpressionCHIMERA BIOENGINEERING INC·Filed 2021·Application pending·0 cites
- 3355US12576135B2Compositions and methods for anti-TnMUC1 gold CAR t-cellsCHIMERA BIOENGINEERING INC·Filed 2022·Granted Mar 17, 2026·0 cites·17 claims
- 3452US2018127776A1Ligand Matched Transcription Control, Control Devices, and Solute CarriersCHIMERA BIOENGINEERING INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CHIMERA BIOENGINEERING INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →